Tong-Ho Lin
7Patents
1h-index
12Co-inventors
44Inventor score
Filing activity: May 17, 2010 → Jan 10, 2020
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8481721B2 | Compositions and methods for increasing telomerase activity | Chemistry; Metallurgy | 3 | Active |
| US9403866B2 | Compositions and methods for increasing telomerase activity | Chemistry; Metallurgy | 1 | Active |
| US12201630B2 | Naltrexone injectable sustained release formulation | Human Necessities | 0 | Active |
| US9913851B2 | Compositions and methods for increasing telomerase activity | Chemistry; Metallurgy | 0 | Active |
| US11524965B2 | Long-acting injectable formulations and crystalline forms of buprenorphine derivatives | Chemistry; Metallurgy | 0 | Active |
| US11981617B2 | Ketamine pamoate and use thereof | Chemistry; Metallurgy | 0 | Active |
| US10744132B2 | Sustained-release buprenorphine formulations | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.